{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:23:48Z","timestamp":1779319428054,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical science research project of Hebei Provincial Health Commission of China","award":["20251629"],"award-info":[{"award-number":["20251629"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11060-025-04999-x","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T08:21:26Z","timestamp":1741854086000},"page":"419-428","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serum exosomal miRNA contributes to the diagnosis of leptomeningeal carcinomatosis"],"prefix":"10.1007","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1334-4683","authenticated-orcid":false,"given":"Jie","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejiao","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiasi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YingLu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"4999_CR1","doi-asserted-by":"publisher","unstructured":"Jan R, Adrienne B (2024) The path to leptomeningeal metastasis. Nat Rev Cancer 24(7). https:\/\/doi.org\/10.1038\/s41568-024-00700-y","DOI":"10.1038\/s41568-024-00700-y"},{"key":"4999_CR2","doi-asserted-by":"publisher","unstructured":"Ahmad O, Hannah W, Debarati B, Nicholas M, Michael G, Stuart AG et al (2024) Leptomeningeal metastatic disease: new frontiers and future directions. Nat Rev Clin Oncol 22(2). https:\/\/doi.org\/10.1038\/s41571-024-00970-3","DOI":"10.1038\/s41571-024-00970-3"},{"key":"4999_CR3","doi-asserted-by":"publisher","unstructured":"Sehhoon P, Richard B, Hyun Ae J, Jong-Mu S, Se-Hoon L, Jin Seok A et al (2024) Phase II Efficacy and Safety of 80\u00a0mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM). J Clin Oncol 42(23). https:\/\/doi.org\/10.1200\/jco.24.00708","DOI":"10.1200\/jco.24.00708"},{"key":"4999_CR4","doi-asserted-by":"publisher","unstructured":"Lindsay A, John WMM, Martin J, vdB, Peter AESS, Stefan S, Agnes J (2018) Novel methods to diagnose leptomeningeal metastases in breast cancer. Neuro Oncol 21(4). https:\/\/doi.org\/10.1093\/neuonc\/noy186","DOI":"10.1093\/neuonc\/noy186"},{"key":"4999_CR5","doi-asserted-by":"publisher","unstructured":"Haiying C, Roman P-S (2018) Leptomeningeal metastases in non-small-cell lung cancer. Lancet Oncol 19(1). (https:\/\/doi.org\/10.1016\/s1470-2045(17)30689-7)","DOI":"10.1016\/s1470-2045(17)30689-7"},{"key":"4999_CR6","doi-asserted-by":"publisher","unstructured":"Raghu K, Kathleen MM (2023) The role of extracellular vesicles in cancer. Cell 186(8). https:\/\/doi.org\/10.1016\/j.cell.2023.03.010","DOI":"10.1016\/j.cell.2023.03.010"},{"key":"4999_CR7","doi-asserted-by":"publisher","unstructured":"Raghu K, Valerie SL (2020) The biology, function, and biomedical applications of exosomes. Science 367(6478). https:\/\/doi.org\/10.1126\/science.aau6977","DOI":"10.1126\/science.aau6977"},{"key":"4999_CR8","doi-asserted-by":"publisher","unstructured":"Sushmaa Chandralekha S, K Auxzilia P, Durairaj S (2023) MicroRNAs as important players in regulating cancer through PTEN\/PI3K\/AKT signalling pathways. Biochim Biophys Acta Rev Cancer 1878(3). https:\/\/doi.org\/10.1016\/j.bbcan.2023.188904","DOI":"10.1016\/j.bbcan.2023.188904"},{"key":"4999_CR9","doi-asserted-by":"publisher","unstructured":"Wei Y, Xiwei W, Weiying Z, Miranda YF, Minghui C, Juan L et al (2018) Cancer-cell-secreted Exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells. Nat Cell Biol 20(5). https:\/\/doi.org\/10.1038\/s41556-018-0083-6","DOI":"10.1038\/s41556-018-0083-6"},{"key":"4999_CR10","doi-asserted-by":"publisher","unstructured":"Mingyang J, Yiji J, Kaicheng L, Fu G, Ke Z, Mingjing X et al (2023) Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1. Mol Cancer 22(1). https:\/\/doi.org\/10.1186\/s12943-023-01804-z","DOI":"10.1186\/s12943-023-01804-z"},{"key":"4999_CR11","doi-asserted-by":"publisher","unstructured":"E LR MW, vdB M (2023) Leptomeningeal metastasis from solid tumours: EANO-ESMO clinical practice guideline for diagnosis, treatment and follow-up. ESMO Open 8(5). https:\/\/doi.org\/10.1016\/j.esmoop.2023.101624","DOI":"10.1016\/j.esmoop.2023.101624"},{"key":"4999_CR12","doi-asserted-by":"publisher","unstructured":"Jyoti M, Isa M, Gregory G, Jeremy F, Arin N, Natalie G et al (2024) Targeting CNS metastases in Non-Small cell lung Cancer with evolving approaches using molecular markers: A review. JAMA Oncol 11(1). https:\/\/doi.org\/10.1001\/jamaoncol.2024.5218","DOI":"10.1001\/jamaoncol.2024.5218"},{"key":"4999_CR13","doi-asserted-by":"publisher","unstructured":"Mark TJ, vB, Dick P, Bojana MK, Mijke B, Karolina S, Doroth\u00e9 TCL et al (2020) Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases. Neurology 94(5). https:\/\/doi.org\/10.1212\/wnl.0000000000008751","DOI":"10.1212\/wnl.0000000000008751"},{"key":"4999_CR14","doi-asserted-by":"publisher","unstructured":"Amanda F, Marjan I, Adam M, Lucy C, Thanussuyah A, Angela C et al (2021) Assessing CSF ctdna to improve diagnostic accuracy and therapeutic monitoring in breast Cancer leptomeningeal metastasis. Clin Cancer Res 28(6). https:\/\/doi.org\/10.1158\/1078-0432.Ccr-21-3017","DOI":"10.1158\/1078-0432.Ccr-21-3017"},{"key":"4999_CR15","doi-asserted-by":"publisher","unstructured":"Leticia DM-A, Regina M, Charlotte KYN, Britta W, Francisco M-R, Davis T et al (2015) Cerebrospinal fluid-derived Circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. Nat Commun 6(0). https:\/\/doi.org\/10.1038\/ncomms9839","DOI":"10.1038\/ncomms9839"},{"key":"4999_CR16","doi-asserted-by":"publisher","unstructured":"Yingmei L, Dina P, Layton L, Ian David C, Eli J, Lina Khav K et al (2021) Comprehensive RNA analysis of CSF reveals a role for CEACAM6 in lung cancer leptomeningeal metastases. NPJ Precis Oncol 5(1). https:\/\/doi.org\/10.1038\/s41698-021-00228-6","DOI":"10.1038\/s41698-021-00228-6"},{"key":"4999_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"D Pegtel","year":"2019","unstructured":"Pegtel D, Gould S, Exosomes (2019) Annu Rev Biochem 88:487\u2013514. https:\/\/doi.org\/10.1146\/annurev-biochem-013118-111902","journal-title":"Annu Rev Biochem"},{"issue":"7578","key":"4999_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino A, Costa-Silva B, Shen T, Rodrigues G, Hashimoto A, Tesic Mark M et al (2015) Tumour exosome integrins determine organotropic metastasis. Nature 527(7578):329\u2013335. https:\/\/doi.org\/10.1038\/nature15756","journal-title":"Nature"},{"key":"4999_CR19","doi-asserted-by":"publisher","unstructured":"Liu Q, Xiang Y, Yuan S, Xie W, Li C, Hu Z et al (2018) Plasma exosome levels in non-small-cell lung cancer: correlation with clinicopathological features and prognostic implications. Cancer biomarkers: section A of disease markers. 22(2):267\u2013274. https:\/\/doi.org\/10.3233\/cbm-170955","DOI":"10.3233\/cbm-170955"},{"issue":"1","key":"4999_CR20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13578-023-01112-5","volume":"13","author":"S Li","year":"2023","unstructured":"Li S, Qu Y, Liu L, Zhang X, He Y, Wang C et al (2023) Comparative proteomic profiling of plasma exosomes in lung cancer cases of liver and brain metastasis. Cell Bioscience 13(1):180. https:\/\/doi.org\/10.1186\/s13578-023-01112-5","journal-title":"Cell Bioscience"},{"key":"4999_CR21","doi-asserted-by":"publisher","unstructured":"Kun Z, Changji J, Jin W, Weiye S, Xiaoying W, Yan S et al (2024) Exosomal hsa-miR-151a-3p and hsa-miR-877-5p are potential novel biomarkers for predicting bone metastasis in lung cancer. Aging 15(24). https:\/\/doi.org\/10.18632\/aging.205314","DOI":"10.18632\/aging.205314"},{"key":"4999_CR22","doi-asserted-by":"publisher","unstructured":"Lee K, Im J, Lin W, Gwak H, Kim J, Yoo B et al (2020) Nanoparticles in 472 human cerebrospinal fluid: changes in extracellular vesicle concentration and miR-21 expression as a biomarker for leptomeningeal metastasis. Cancers 12(10). https:\/\/doi.org\/10.3390\/cancers12102745","DOI":"10.3390\/cancers12102745"},{"issue":"1","key":"4999_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/02648725.2023.2183613","volume":"40","author":"H Li","year":"2024","unstructured":"Li H, Xia M, Zheng S, Lin Y, Yu T, Xie Y et al (2024) Cerebrospinal fluid Exosomal MicroRNAs as biomarkers for diagnosing or monitoring the progression of non-small cell lung cancer with leptomeningeal metastases. Biotechnol Genet Eng Rev 40(1):359\u2013380. https:\/\/doi.org\/10.1080\/02648725.2023.2183613","journal-title":"Biotechnol Genet Eng Rev"},{"key":"4999_CR24","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.2147\/ott.S291611","volume":"14","author":"Q Xu","year":"2021","unstructured":"Xu Q, Ye L, Huang L, Zhou L, Chen X, Ye M et al (2021) Serum Exosomal MiRNA might be a novel liquid biopsy to identify leptomeningeal metastasis in Non-Small cell lung Cancer. OncoTargets Therapy 14:2327\u20132335. https:\/\/doi.org\/10.2147\/ott.S291611","journal-title":"OncoTargets Therapy"},{"key":"4999_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.omtn.2019.07.025","volume":"18","author":"R Ji","year":"2019","unstructured":"Ji R, Zhang X, Gu H, Ma J, Wen X, Zhou J et al (2019) miR-374a-5p: A new target for diagnosis and drug resistance therapy in gastric Cancer. Mol Therapy Nucleic Acids 18:320\u2013331. https:\/\/doi.org\/10.1016\/j.omtn.2019.07.025","journal-title":"Mol Therapy Nucleic Acids"},{"key":"4999_CR26","doi-asserted-by":"publisher","unstructured":"Jie J, Yumeng C, Huicong N, Yanli L, Xiaojie W, Xuejiao Q et al (2024) NSCLC extracellular vesicles containing miR-374a-5p promote leptomeningeal metastasis by influencing Blood\u2013Brain barrier permeability. Mol Cancer Res 22(8). https:\/\/doi.org\/10.1158\/1541-7786.Mcr-24-0052","DOI":"10.1158\/1541-7786.Mcr-24-0052"},{"key":"4999_CR27","doi-asserted-by":"publisher","unstructured":"Qing C, Lin Z, De M, Juan H, Yuxin L, Jie W et al (2022) LncRNA GAS6-AS1 facilitates tumorigenesis and metastasis of colorectal cancer by regulating TRIM14 through miR-370-3p\/miR-1296-5p and FUS. J Transl Med 20(1). https:\/\/doi.org\/10.1186\/s12967-022-03550-0","DOI":"10.1186\/s12967-022-03550-0"},{"key":"4999_CR28","doi-asserted-by":"publisher","unstructured":"Shan H, Ziming L, Yongfeng Y, Qingyu Z, Yirui C, Wenxiang J et al (2019) Exosomal miR-499a-5p promotes cell proliferation, migration and EMT via mTOR signaling pathway in lung adenocarcinoma. Exp Cell Res 379(2). https:\/\/doi.org\/10.1016\/j.yexcr.2019.03.035","DOI":"10.1016\/j.yexcr.2019.03.035"},{"key":"4999_CR29","doi-asserted-by":"publisher","unstructured":"Siqi P, Yutong C, Ting L, Junjie M, Pengfei Y, Baojia Z et al (2022) Hsa-microRNA-370-3p targeting snail and Twist1 suppresses IL-8\/STAT3-driven hepatocellular carcinoma metastasis. Cancer Sci 113(12). https:\/\/doi.org\/10.1111\/cas.15571","DOI":"10.1111\/cas.15571"},{"key":"4999_CR30","doi-asserted-by":"publisher","unstructured":"Mengying N, Hong L, Xu L, Xiaoqian Y, Aijun M, Xudong P et al (2021) Circulating Exosomal MiRNAs as novel biomarkers perform superior diagnostic efficiency compared with plasma MiRNAs for Large-Artery atherosclerosis stroke. Front Pharmacol 12(0). https:\/\/doi.org\/10.3389\/fphar.2021.791644","DOI":"10.3389\/fphar.2021.791644"},{"key":"4999_CR31","doi-asserted-by":"publisher","unstructured":"Ilona H, Katerina K, Lenka D, Ladislav K (2020) Evaluation of vascular endothelial function in young and Middle-Aged women with respect to a history of pregnancy, Pregnancy-Related complications, classical cardiovascular risk factors, and epigenetics. Int J Mol Sci 21(2). https:\/\/doi.org\/10.3390\/ijms21020430","DOI":"10.3390\/ijms21020430"},{"key":"4999_CR32","doi-asserted-by":"publisher","unstructured":"Caifeng G, Weichun M, Kunlun W, Mingqiang G, Junfeng C, Feng Z et al (2023) Exosomal miR-370-3p increases the permeability of blood-brain barrier in ischemia\/reperfusion stroke of brain by targeting MPK1. Aging 15(6). https:\/\/doi.org\/10.18632\/aging.204573","DOI":"10.18632\/aging.204573"},{"key":"4999_CR33","doi-asserted-by":"publisher","unstructured":"Sushmaa Chandralekha S, Auxzilia PK, Durairaj S (2024) MicroRNA-510-3p regulated vascular dysfunction in preeclampsia by targeting vascular endothelial growth factor A (VEGFA) and its signaling axis. Placenta 153(0). https:\/\/doi.org\/10.1016\/j.placenta.2024.05.135","DOI":"10.1016\/j.placenta.2024.05.135"},{"key":"4999_CR34","doi-asserted-by":"publisher","unstructured":"Mani P, R M V MB, Durairaj PSSRS (2018) Dissecting the role of miR-21 in different types of stroke. Gene 681(0). https:\/\/doi.org\/10.1016\/j.gene.2018.09.048)","DOI":"10.1016\/j.gene.2018.09.048"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-04999-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-04999-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-04999-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T08:45:00Z","timestamp":1748249100000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-04999-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["4999"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-04999-x","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research using human serum samples was approved by the Ethics Committee of the Second Hospital of Hebei Medical University and was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}